Applications of Etiocholanone in Industrial Manufacturing

Etiocholanone serves specialized roles within pharmaceutical and chemical manufacturing, primarily as a steroid intermediate. As the original manufacturer, we supply material meeting precise industry requirements. Below are the major downstream industrial application sectors, each with unique compliance, usage, integration processes, and end products relevant to global production standards.

1. Pharmaceutical Steroid Synthesis

Pharmaceutical producers use etiocholanone as a key intermediate to manufacture corticosteroids, androgens, and certain hormonal medications. Chemical process design dictates its use in multi-step synthesis, often at the hydrogenation or reduction stage to construct or modify steroid nuclei. Manufacturers select batch or continuous processing to control purity and yield based on the final API target, as strict regulatory guidelines govern every input material at this stage.

Industry compliance standards

• Current Good Manufacturing Practice (cGMP, 21 CFR Parts 210 & 211, FDA)
• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) & United States Pharmacopeia–National Formulary (USP–NF) for intermediates
• Certificate of Suitability to the Monographs of the European Pharmacopoeia (CEP)

Typical usage ratio

• Usage depends on the synthetic route, typically 20–40% molar ratio relative to target steroid nucleus precursor
• Adjusted according to reaction yield, purity requirements, and API output scale

Downstream process integration

• Enters after initial ring structure formation as the C-19 ketone donor in steroid backbone transformation
• Utilized in controlled hydrogenation, reduction, or oxidation steps to modify steroid functional groups
• QC sampling and analytical HPLC at intermediate and pre-final API stages

Final product types

• Corticosteroids (e.g. hydrocortisone, prednisone intermediates)
• Androgenic drugs (such as testosterone derivatives)
• Steroidal anti-inflammatory APIs
• API-grade intermediates for hospital-use injectables and oral tablets

2. Research Reagents for Metabolic Pathway Studies

Life science and academic laboratories use etiocholanone as a research chemical to study steroid metabolism, enzyme pathways, and receptor binding. Controlled conditions allow precise tracing and quantification in metabolic assays or reference standards. Traceability, documentation, and analytical grade quality are mandatory to validate results and support scientific publication or regulatory submissions.

Industry compliance standards

• ISO 9001-certified laboratory supply systems
• OECD Good Laboratory Practice (GLP) for analytical reference materials
• REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) registration for R&D chemicals in Europe
• Material Safety Data Sheet (MSDS) requirements for chemical laboratories

Typical usage ratio

• Standard solutions: 1–100 µM concentrations in buffer or solvent, depending on assay sensitivity
• Tracer or substrate applications: 0.05–0.2 mg per 1 mL reaction mixture

Downstream process integration

• Weighing and dissolution in analytical-grade solvents
• Preparation of stock solutions and dilutions for metabolic, enzyme, or receptor binding assays
• Quantitative analysis via LC–MS, GC–MS, or immunoassay platforms

Final product types

• Certified laboratory reference standards
• Biochemical metabolic pathway assays
• Steroid hormone signaling research kits
• Enzyme substrate and inhibitor characterizations

3. Diagnostic Kit Intermediate Manufacturing

Producers of clinical diagnostic kits employ etiocholanone as an essential intermediate for steroid metabolite calibration in immunoassays and chromatographic test systems. Purified material supports the standardization of controls and calibrators used in automated pathology labs for hormone profiling or endocrine disorder testing. Manufacturing records and analytical validation files are required for each production lot to support traceability and external audits by regulatory agencies.

Industry compliance standards

• ISO 13485: Medical Devices – QMS for in vitro diagnostics
• IVDR (EU) 2017/746 for diagnostic kit materials
• FDA 21 CFR Part 820 (Quality System Regulation for medical devices)
• CLSI (Clinical & Laboratory Standards Institute) guidelines for reference and calibration material

Typical usage ratio

• Calibration controls: typically 1–10 ng/mL concentration in kit matrix
• Internal standards: 20–50 µg per test batch, depending on assay format

Downstream process integration

• Dissolution in aqueous or organic matrix during kit assembly
• Integration during manufacture of calibrator or control vials
• Analytical cross-verification against NIST or certified reference standards

Final product types

• Steroid metabolite ELISA kits
• Quality control calibrators for LC–MS/MS diagnostic panels
• Immunoassay standards for endocrine function testing
• Specimen validation sets for hospital laboratory systems

4. Intermediate for Veterinary Pharmaceutical Compounds

Veterinary medicine manufacturers use etiocholanone as a starting compound for synthesizing steroid-based formulations for livestock, equine, and companion animal health. Synthesis follows veterinary GMP procedures, requiring raw material traceability and QA release. Formulators target specific modifications for anti-inflammatory, reproductive, or growth-regulating medications, integrating the intermediate during early-stage batch API production or preformulation steps for injectable or oral veterinary products.

Industry compliance standards

• VICH GL24: Good Manufacturing Practice for active pharmaceutical ingredients used in veterinary medicines
• US FDA: Guidance for Industry – Veterinary Drug Residue Limits
• EU Regulation 2019/6 on veterinary medicinal products
• ISO/IEC 17025: Testing and calibration certificates for veterinary APIs

Typical usage ratio

• API manufacturing: 10–30% of total input intermediates, varies with end-use specification
• Formulation adjustability based on targeted veterinary species

Downstream process integration

• Charged during initial chemical synthesis stage for steroidal structure development
• Subject to in-process QC and purity testing before downstream extraction or crystallization
• Released to final API stage with documented batch records for regulatory release

Final product types

• Veterinary corticosteroid injectables
• Oral hormone therapies for reproductive management
• Livestock growth-promoting formulations (subject to regional legislation)
• Specialty anti-inflammatory agents for equine and companion animals